Details of the Drug Reposition

General Information of This Drug (ID: DM3OJXO)

Drug Name
V-419   DM3OJXO
Synonyms
Liquid hexavalent combination pediatric vaccine, Merck; HR-5-I (alternative liquid formulations), Merck; Alternative liquid formulation pediatric vaccine (diphtheria, tetanus, pertussis, polio, HBV, Hib), Merck; Diphtheria, tetanus, pertussis, polio, HBV, Haemophilus influenzae vaccine (alternative liquid formulations), Merck

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Generalized anxiety disorder DISPSQCW 6B00 Phase 3 [1]
------------------------------------------------------------------------------------
1 Application submitted Indication(s)
Indication Name Indication ID ICD-11 Status REF
Poliovirus infection DISEU9EO 1C8Y Application submitted [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01337167) Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13 and RotaTeq (V419-005 AM4). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)